13F Insight
DOSSIER · 13F-HR · Q1 2026

QVIDTVM Management LLC

$81M in tracked AUM across 14 positions as of Q1 2026.

QM
CIK 0001912226 · last filed Mar 31, 2026
Total AUM
$81M
as of Q1 2026
Holdings
14
—
positions
Whale Score
65
65
tracked
Activity
—
no data
changes this Q
AI Analysis · Q1 2026

Portfolio Overview

QVIDTVM Management LLC reported a significant contraction in its portfolio for the period ending September 30, 2025. The total asset under management (AUM) dropped by 51.1%, declining from $99.85 million in the previous quarter to $48.85 million. This reduction is driven by a combination of asset reallocation and the exiting of major equity positions rather than solely market depreciation. The portfolio is currently highly concentrated, holding only 4 distinct securities....

Key Holdings

The portfolio is dominated by a single massive position in SOLVENTUM CORP (SOLV), which comprises 74.22% of the total portfolio value ($36.26 million). This extreme concentration implies that the firm’s performance is inextricably linked to the fortunes of this single healthcare entity. The second largest holding is DENTSPLY SIRONA INC (XRAY), representing 12.86% of the portfolio ($6.28 million). Notably, QVIDTVM increased its stake in XRAY by 6.8% during the quarter, adding approximately $1.08 million, signaling a continued bullish stance on the dental equipment manufacturer despite the overall portfolio shrinkage.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
BIO
BIO RAD LABS INC
$23M84K28.7%02
SOLV
SOLVENTUM CORP
$17M266K21.3%03
H2927K103
AMRIZE LTD
$12M217K15.0%04
N97284108
NEBIUS GROUP N.V.
$6M61K7.7%05
ORCL
ORACLE CORP
$6M39K7.0%06
N30577105
ERMENEGILDO ZEGNA N V
$5M526K6.7%07
XRAY
DENTSPLY SIRONA INC
$4M385K5.5%08
BRCC
BRC INC
$3M3.4M3.2%09
ARE
ALEXANDRIA REAL ESTATE EQ IN
$2M40K2.3%10
HRB
BLOCK H & R INC
$738K23K0.9%

Filing history

2026Q1Mar 31
$81M▼ 7.9%
14 positionsView →2025Q4Dec 31
$88M▲ 80.9%
13 positionsView →2025Q3Sep 30
$49M▼ 51.1%
4 positionsView →2025Q2Jun 30
$100M▲ 78.2%
8 positionsLocked2025Q1Mar 31
$56M▼ 54.9%
4 positionsLocked2024Q4Dec 31
$124M▼ 13.1%
8 positionsLocked2024Q3Sep 30
$143M▲ 14.3%
8 positionsLocked2024Q2Jun 30
$125M▲ 0.7%
7 positionsLocked2024Q1Mar 31
$124M▲ 4.6%
10 positionsLocked2023Q4Dec 31
$119M▼ 7.8%
9 positionsLocked2023Q3Sep 30
$129M▼ 20.8%
11 positionsLocked2023Q2Jun 30
$163M▼ 0.2%
12 positionsLocked
Showing 12 of 18